A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents-Reference-Cited by-同舟云学术

A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents

Published:2013-08-19 Issue:1 Volume:16 Page:75-85
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Tatarkiewicz K.¹,Hargrove D. M.¹,Jodka C. M.¹,Gedulin B. R.¹,Smith P. A.¹,Hoyt J. A.¹,Lwin A.¹,Collins L.¹,Mamedova L.¹,Levy O. E.¹,D'Souza L.¹,Janssen S.¹,Srivastava V.¹,Ghosh S. S.¹,Parkes D. G.¹

Affiliation:

1. Amylin Pharmaceuticals; LLC; San Diego CA USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12181/fullpdf

Reference39 articles.

1. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns;Elliott;J Endocrinol,1993

2. Diurnal variation of plasma gastric inhibitory polypeptide in man;Jorde;Scand J Gastroenterol,1980

3. Stimulation of insulin secretion by gastric inhibitory polypeptide in man;Dupre;J Clin Endocrinol Metabol,1973

4. Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog;Pederson;Diabetes,1975

5. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels;Andersen;J Clin Invest,1978

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes;Peptides;2024-04

2. Gut-Derived Peptide Hormone Analogues and Potential Treatment of Bone Disorders in Obesity and Diabetes Mellitus;Clinical Medicine Insights: Endocrinology and Diabetes;2024-01

3. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment;Pharmacological Research;2022-12

4. The evolving story of incretins ( GIP and GLP ‐1) in metabolic and cardiovascular disease: A pathophysiological update;Diabetes, Obesity and Metabolism;2021-09

5. Exendin(9‐39) NH 2 : Recommendations for clinical use based on a systematic literature review;Diabetes, Obesity and Metabolism;2021-08-23